Bridgeway Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bridgeway Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Sell	860 -3,000	-78%	-$1.68M	0.01%	870
2026 Q1	$2.17M	Hold	3,860	–	–	0.04%	509
2025 Q4	$2.61M	Buy	+3,860	New	+$2.63M	0.05%	448
2024 Q2	–	Sell	-3,200	Closed	-$1.73M	–	1303
2024 Q1	$1.73M	Hold	3,200	–	–	0.04%	615
2023 Q4	$1.78M	Buy	+3,200	New	+$1.5M	0.04%	623
2023 Q1	–	Sell	-4,990	Closed	-$2.04M	–	1404
2022 Q4	$2.04M	Hold	4,990	–	–	0.05%	548
2022 Q3	$1.63M	Sell	4,990 -8,600	-63%	-$3.16M	0.04%	602
2022 Q2	$4.77M	Hold	13,590	–	–	0.11%	329
2022 Q1	$7.43M	Hold	13,590	–	–	0.14%	249
2021 Q4	$8.95M	Hold	13,590	–	–	0.17%	192
2021 Q3	$8.45M	Hold	13,590	–	–	0.16%	190
2021 Q2	$8.58M	Buy	13,590 +8,540	+169%	+$4.72M	0.15%	185
2021 Q1	$2.47M	Hold	5,050	–	–	0.05%	512
2020 Q4	$2.52M	Buy	+5,050	New	+$2.26M	0.05%	437
2018 Q4	–	Sell	-58,800	Closed	-$14.7M	–	1414
2018 Q3	$14.7M	Hold	58,800	–	–	0.14%	139
2018 Q2	$12.8M	Hold	58,800	–	–	0.13%	148
2018 Q1	$11.3M	Hold	58,800	–	–	0.12%	146
2017 Q4	$9.2M	Hold	58,800	–	–	0.1%	172
2017 Q3	$9.14M	Buy	58,800 +9,400	+19%	+$1.49M	0.1%	159
2017 Q2	$7.97M	Hold	49,400	–	–	0.1%	166
2017 Q1	$7.64M	Hold	49,400	–	–	0.09%	170
2016 Q4	$5.79M	Hold	49,400	–	–	0.08%	228
2016 Q3	$5.57M	Hold	49,400	–	–	0.08%	217
2016 Q2	$4.59M	Buy	+49,400	New	+$4.24M	0.07%	257

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bridgeway Capital Management's IDXX Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Idexx Laboratories (IDXX) stake by 78% in Q2 2026, selling an estimated $1.68M and leaving 860 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #870.

Bridgeway Capital Management first reported a position in IDXX in Q2 2016 and has held it in 24 quarters since. The position peaked at $14.7M in Q3 2018. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Bridgeway Capital Management held 860 shares of Idexx Laboratories worth $453K as of Q2 2026.
Bridgeway Capital Management sold 3,000 Idexx Laboratories shares in Q2 2026, an estimated $1.68M.
Idexx Laboratories made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #870 holding.
Bridgeway Capital Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 24 quarters since.
Bridgeway Capital Management's Idexx Laboratories position peaked at $14.7M in Q3 2018.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.